Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.
about
The efficacy of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin in advanced colorectal cancer (preliminary data).A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyGemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016)Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsOxaliplatin: a review of evolving concepts.Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cellsReview article: colorectal cancer chemotherapy.Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinomaAnti-proliferative activity and mechanism of action of titanocene dichloride.Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.Advances in the adjuvant treatment of colorectal cancer.Unique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma.Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by inductively coupled plasma mass spectrometry (ICP-MS).Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.A tetrazolato-bridged dinuclear platinum(II) complex exhibits markedly high in vivo antitumor activity against pancreatic cancer.Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy.Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
P2860
Q33389163-48391F5E-553B-4EF7-B8C5-9B9D78128D9EQ33390957-3751B8E8-3CBF-4728-A084-26981191BA1FQ33414629-B86518B5-79D8-4273-AB7F-BCC9E6504148Q33800645-BD36EEDB-FBD4-458E-859A-FEF61B03BF9FQ33845471-D557ED90-6333-41A6-9D53-97B8BD0E3E3BQ34008793-96547F07-A297-4E28-B6AE-6947276BC1A1Q34569008-07D8D34C-E659-469D-946E-01A8A3800090Q35381023-BB94213F-5B33-4AF9-8AD0-583688BBBD68Q35544078-752F4768-958F-43F9-8B1E-BEF32928E55EQ36224938-B5E8818F-567F-4690-915E-24439494F814Q36292954-3A8CF754-C043-495A-9AFC-CCB48F7556FDQ36364465-1AAF906A-ED83-452B-AA84-49D592D7CD89Q36503798-FF7C2212-6676-4F3F-A2DF-F1C678649A6BQ37868960-06F9FBF2-CD50-4DF5-871D-010BB91C2D32Q38768797-7A5E9C25-9229-433B-9424-AEA3AE105928Q39024229-E34FE43A-A14A-46A8-A00B-969FFDFEE9C3Q39162262-7A3367EB-D738-4E1E-82B2-4706DA9507DEQ39550844-B5A1779C-848A-4870-98DE-5FAF8162FC97Q39557153-98246E7F-EC48-4C1E-93D8-42553FA657C1Q39639803-4D5645A7-6A0F-4DE5-A89F-E47237B35856Q40065125-EBD4018E-065C-441D-820A-1B92A3857C37Q42806227-4F7ED5EC-F5BA-42BA-B8AE-A19F4695C885Q45159072-DDF7FDFD-EC2C-4531-9019-1AA928E14877Q45257462-B159AFCC-DBB0-461E-BFBB-871355B9AE5DQ48773255-7AA54773-222A-4E03-BB39-EED6DEC81A3B
P2860
Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
Antitumor activity of a new pl ...... m (II): new experimental data.
@ast
Antitumor activity of a new pl ...... m (II): new experimental data.
@en
type
label
Antitumor activity of a new pl ...... m (II): new experimental data.
@ast
Antitumor activity of a new pl ...... m (II): new experimental data.
@en
prefLabel
Antitumor activity of a new pl ...... m (II): new experimental data.
@ast
Antitumor activity of a new pl ...... m (II): new experimental data.
@en
P2093
P1476
Antitumor activity of a new pl ...... m (II): new experimental data.
@en
P2093
P304
P356
10.1016/0753-3322(89)90004-8
P577
1989-01-01T00:00:00Z